Logo image of TRC

TEJON RANCH CO (TRC) Stock Fundamental Analysis

NYSE:TRC - New York Stock Exchange, Inc. - US8790801091 - Common Stock - Currency: USD

16.465  -0.09 (-0.57%)

Fundamental Rating

3

TRC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. TRC has an average financial health and profitability rating. TRC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

TRC had positive earnings in the past year.
In the past year TRC had a positive cash flow from operations.
Of the past 5 years TRC 4 years were profitable.
In the past 5 years TRC always reported a positive cash flow from operatings.
TRC Yearly Net Income VS EBIT VS OCF VS FCFTRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

The Return On Assets of TRC (0.44%) is better than 62.50% of its industry peers.
TRC has a Return On Equity of 0.57%. This is in the better half of the industry: TRC outperforms 62.50% of its industry peers.
Industry RankSector Rank
ROA 0.44%
ROE 0.57%
ROIC N/A
ROA(3y)1.27%
ROA(5y)0.93%
ROE(3y)1.56%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
TRC Yearly ROA, ROE, ROICTRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3

1.3 Margins

With an excellent Profit Margin value of 6.42%, TRC belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
TRC's Profit Margin has declined in the last couple of years.
TRC has a Gross Margin of 4.52%. This is in the lower half of the industry: TRC underperforms 75.00% of its industry peers.
TRC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 6.42%
GM 4.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.59%
PM growth 5Y-21.37%
GM growth 3Y-35.98%
GM growth 5Y-22.35%
TRC Yearly Profit, Operating, Gross MarginsTRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

5

2. Health

2.1 Basic Checks

TRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
TRC has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for TRC has been increased compared to 5 years ago.
The debt/assets ratio for TRC is higher compared to a year ago.
TRC Yearly Shares OutstandingTRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
TRC Yearly Total Debt VS Total AssetsTRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

TRC has an Altman-Z score of 2.37. This is not the best score and indicates that TRC is in the grey zone with still only limited risk for bankruptcy at the moment.
TRC's Altman-Z score of 2.37 is fine compared to the rest of the industry. TRC outperforms 67.19% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that TRC is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.14, TRC is doing good in the industry, outperforming 73.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 2.37
ROIC/WACCN/A
WACC8.4%
TRC Yearly LT Debt VS Equity VS FCFTRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

TRC has a Current Ratio of 4.13. This indicates that TRC is financially healthy and has no problem in meeting its short term obligations.
TRC has a Current ratio of 4.13. This is amongst the best in the industry. TRC outperforms 82.81% of its industry peers.
TRC has a Quick Ratio of 3.90. This indicates that TRC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.90, TRC belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.13
Quick Ratio 3.9
TRC Yearly Current Assets VS Current LiabilitesTRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

TRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.54%.
Measured over the past years, TRC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.17% on average per year.
TRC shows a decrease in Revenue. In the last year, the revenue decreased by -6.38%.
TRC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.29% yearly.
EPS 1Y (TTM)-17.54%
EPS 3Y-19.39%
EPS 5Y-24.17%
EPS Q2Q%183.33%
Revenue 1Y (TTM)-6.38%
Revenue growth 3Y-9.02%
Revenue growth 5Y-3.29%
Sales Q2Q%10.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-8.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRC Yearly Revenue VS EstimatesTRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
TRC Yearly EPS VS EstimatesTRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.2 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 149.68, TRC can be considered very expensive at the moment.
TRC's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of TRC to the average of the S&P500 Index (28.29), we can say TRC is valued expensively.
TRC is valuated quite expensively with a Price/Forward Earnings ratio of 163.02.
67.19% of the companies in the same industry are more expensive than TRC, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, TRC is valued quite expensively.
Industry RankSector Rank
PE 149.68
Fwd PE 163.02
TRC Price Earnings VS Forward Price EarningsTRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRC Per share dataTRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TRC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TEJON RANCH CO

NYSE:TRC (4/21/2025, 2:01:43 PM)

16.465

-0.09 (-0.57%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-06 2025-03-06/bmo
Earnings (Next)05-12 2025-05-12
Inst Owners62.53%
Inst Owner Change-0.07%
Ins Owners5.38%
Ins Owner Change0.7%
Market Cap442.41M
Analysts0
Price Target26.78 (62.65%)
Short Float %2.07%
Short Ratio5.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-66.01%
Min EPS beat(2)-593.07%
Max EPS beat(2)461.06%
EPS beat(4)2
Avg EPS beat(4)-9.28%
Min EPS beat(4)-593.07%
Max EPS beat(4)461.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.92%
Min Revenue beat(2)5.51%
Max Revenue beat(2)14.33%
Revenue beat(4)2
Avg Revenue beat(4)-11.63%
Min Revenue beat(4)-41.48%
Max Revenue beat(4)14.33%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)233.33%
EPS NY rev (3m)233.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.32%
Revenue NY rev (3m)-9.32%
Valuation
Industry RankSector Rank
PE 149.68
Fwd PE 163.02
P/S 10.56
P/FCF N/A
P/OCF 30.91
P/B 0.93
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)0.11
EY0.67%
EPS(NY)0.1
Fwd EY0.61%
FCF(TTM)-1.93
FCFYN/A
OCF(TTM)0.53
OCFY3.24%
SpS1.56
BVpS17.63
TBVpS15.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 0.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.42%
GM 4.52%
FCFM N/A
ROA(3y)1.27%
ROA(5y)0.93%
ROE(3y)1.56%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.59%
PM growth 5Y-21.37%
GM growth 3Y-35.98%
GM growth 5Y-22.35%
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1353.29%
Cap/Sales 157.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.13
Quick Ratio 3.9
Altman-Z 2.37
F-Score3
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)810.78%
Cap/Depr(5y)692.45%
Cap/Sales(3y)82.92%
Cap/Sales(5y)71.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.54%
EPS 3Y-19.39%
EPS 5Y-24.17%
EPS Q2Q%183.33%
EPS Next Y-8.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.38%
Revenue growth 3Y-9.02%
Revenue growth 5Y-3.29%
Sales Q2Q%10.94%
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-148.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-277.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.83%
OCF growth 3Y71.94%
OCF growth 5Y-2.26%